First Trust Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-78,199
Closed -$7.27M 301
2021
Q4
$7.27M Buy
+78,199
New +$5.15M 1.27% 11

First Trust Capital Management's ARNA Position: Q1 2022 in Review

First Trust Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 78,199 shares — an estimated $7.27M sold.

First Trust Capital Management first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $7.27M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • First Trust Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • First Trust Capital Management sold 78,199 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $7.27M.
  • First Trust Capital Management first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
  • First Trust Capital Management's Arena Pharmaceuticals Inc position peaked at $7.27M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on First Trust Capital Management's 13F filing for Q1 2022, filed 16 May 2022.